By Galen Care Partners on Friday, 05 January 2018
Category: Galen Care Partners News

Lower IV Iron Dosing in Anemic Dialysis Patients May Be More Effective

To support ESA therapy, IV iron at doses below 300 mg/month may be most effective for the average hemodialysis patient, according to an observational study.
Original link
Leave Comments